Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In this study, we investigated the expression and function of p53R2 and hRRM2 after UV treatment in human prostate cancer PC3 cells, which possess mutant p53 with a truncated COOH-terminal, and in human oropharyngeal cancer KB cells, which possess wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP548222.RAflO9M8ZgwwkF6CNuznFTWuVJUam5pq4oZIIgk9fWlCo130_assertion description "[In this study, we investigated the expression and function of p53R2 and hRRM2 after UV treatment in human prostate cancer PC3 cells, which possess mutant p53 with a truncated COOH-terminal, and in human oropharyngeal cancer KB cells, which possess wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548222.RAflO9M8ZgwwkF6CNuznFTWuVJUam5pq4oZIIgk9fWlCo130_provenance.
• NP460838.RAsOTYORK8vQtv7Dm0pgrpppRB8On-UALeAu88S-0n1Mg130_assertion description "[In this study, we investigated the expression and function of p53R2 and hRRM2 after UV treatment in human prostate cancer PC3 cells, which possess mutant p53 with a truncated COOH-terminal, and in human oropharyngeal cancer KB cells, which possess wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP460838.RAsOTYORK8vQtv7Dm0pgrpppRB8On-UALeAu88S-0n1Mg130_provenance.
• NP612488.RAtBo0ZSHVI8iYaFfsM-aSo_n-JYiNoJzK4KLeFETlNF8130_assertion description "[In this study, we investigated the expression and function of p53R2 and hRRM2 after UV treatment in human prostate cancer PC3 cells, which possess mutant p53 with a truncated COOH-terminal, and in human oropharyngeal cancer KB cells, which possess wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP612488.RAtBo0ZSHVI8iYaFfsM-aSo_n-JYiNoJzK4KLeFETlNF8130_provenance.
• NP868880.RAU1uDwxu1dkNGDsYxfkP2oiCxGwr7cjIMkkF3VnBqsfk130_assertion description "[In this study, we investigated the expression and function of p53R2 and hRRM2 after UV treatment in human prostate cancer PC3 cells, which possess mutant p53 with a truncated COOH-terminal, and in human oropharyngeal cancer KB cells, which possess wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868880.RAU1uDwxu1dkNGDsYxfkP2oiCxGwr7cjIMkkF3VnBqsfk130_provenance.
• NP711438.RASX8jE46Xw2FA0O-UcN07_doMWdHMnThSOUvo-CGj6Gk130_assertion description "[In this study, we investigated the expression and function of p53R2 and hRRM2 after UV treatment in human prostate cancer PC3 cells, which possess mutant p53 with a truncated COOH-terminal, and in human oropharyngeal cancer KB cells, which possess wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711438.RASX8jE46Xw2FA0O-UcN07_doMWdHMnThSOUvo-CGj6Gk130_provenance.
• NP754847.RAXc0Kfx3IHLbwhMIHDFPkqvqymAHtUG1zaemwrqRR_NU130_assertion description "[In this study, we investigated the expression and function of p53R2 and hRRM2 after UV treatment in human prostate cancer PC3 cells, which possess mutant p53 with a truncated COOH-terminal, and in human oropharyngeal cancer KB cells, which possess wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754847.RAXc0Kfx3IHLbwhMIHDFPkqvqymAHtUG1zaemwrqRR_NU130_provenance.
• NP751679.RAUqUfMn5vxgyd-1Ag-jm47BuuDRfHtf7Xqdb55CgUUOc130_assertion description "[In this study, we investigated the expression and function of p53R2 and hRRM2 after UV treatment in human prostate cancer PC3 cells, which possess mutant p53 with a truncated COOH-terminal, and in human oropharyngeal cancer KB cells, which possess wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP751679.RAUqUfMn5vxgyd-1Ag-jm47BuuDRfHtf7Xqdb55CgUUOc130_provenance.
• NP418537.RAT4FJgFys47EanPCLUB6SUsiZmt_Z7S08rUjrdYg6x6k130_assertion description "[In this study, we investigated the expression and function of p53R2 and hRRM2 after UV treatment in human prostate cancer PC3 cells, which possess mutant p53 with a truncated COOH-terminal, and in human oropharyngeal cancer KB cells, which possess wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418537.RAT4FJgFys47EanPCLUB6SUsiZmt_Z7S08rUjrdYg6x6k130_provenance.
• NP896110.RAODVu5fGZ2QVbTdBAumOrUZptz0ah8FuZQJNh6ys2EqA130_assertion description "[In this study, we investigated the expression and function of p53R2 and hRRM2 after UV treatment in human prostate cancer PC3 cells, which possess mutant p53 with a truncated COOH-terminal, and in human oropharyngeal cancer KB cells, which possess wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP896110.RAODVu5fGZ2QVbTdBAumOrUZptz0ah8FuZQJNh6ys2EqA130_provenance.
• NP897208.RAgTef9760GA-hEitMROTfU7qBNoQbVAKxFFxIJBl-UWs130_assertion description "[In this study, we investigated the expression and function of p53R2 and hRRM2 after UV treatment in human prostate cancer PC3 cells, which possess mutant p53 with a truncated COOH-terminal, and in human oropharyngeal cancer KB cells, which possess wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP897208.RAgTef9760GA-hEitMROTfU7qBNoQbVAKxFFxIJBl-UWs130_provenance.
• NP897232.RAno_TeRvd_rjGjS-oNxoM880wT_xkK3LOTuZr46SnBqk130_assertion description "[In this study, we investigated the expression and function of p53R2 and hRRM2 after UV treatment in human prostate cancer PC3 cells, which possess mutant p53 with a truncated COOH-terminal, and in human oropharyngeal cancer KB cells, which possess wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP897232.RAno_TeRvd_rjGjS-oNxoM880wT_xkK3LOTuZr46SnBqk130_provenance.
• NP418535.RAp-Hq4J64LoRIvr_0NZjiCla1HWFFiRCJCXl4BUwl-vQ130_assertion description "[In this study, we investigated the expression and function of p53R2 and hRRM2 after UV treatment in human prostate cancer PC3 cells, which possess mutant p53 with a truncated COOH-terminal, and in human oropharyngeal cancer KB cells, which possess wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418535.RAp-Hq4J64LoRIvr_0NZjiCla1HWFFiRCJCXl4BUwl-vQ130_provenance.
• NP418538.RAsr76kbuKLmhkWH1NanrxsBEM75QXKfRsGsrtSp-8Y_o130_assertion description "[In this study, we investigated the expression and function of p53R2 and hRRM2 after UV treatment in human prostate cancer PC3 cells, which possess mutant p53 with a truncated COOH-terminal, and in human oropharyngeal cancer KB cells, which possess wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418538.RAsr76kbuKLmhkWH1NanrxsBEM75QXKfRsGsrtSp-8Y_o130_provenance.
• NP418540.RAo-as3fY7UgJzefJA8RyGU3SJS_LL324EdibWOJYe26k130_assertion description "[In this study, we investigated the expression and function of p53R2 and hRRM2 after UV treatment in human prostate cancer PC3 cells, which possess mutant p53 with a truncated COOH-terminal, and in human oropharyngeal cancer KB cells, which possess wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418540.RAo-as3fY7UgJzefJA8RyGU3SJS_LL324EdibWOJYe26k130_provenance.
• NP418541.RAoM4ftCGkCKeW_e4MBQRselc7O2f5VFg6IjNvHfg66V0130_assertion description "[In this study, we investigated the expression and function of p53R2 and hRRM2 after UV treatment in human prostate cancer PC3 cells, which possess mutant p53 with a truncated COOH-terminal, and in human oropharyngeal cancer KB cells, which possess wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418541.RAoM4ftCGkCKeW_e4MBQRselc7O2f5VFg6IjNvHfg66V0130_provenance.
• NP897196.RAIz_Hpff7rUueE575KvsvjJ69a_NoExcQHG6ykI-xnmM130_assertion description "[In this study, we investigated the expression and function of p53R2 and hRRM2 after UV treatment in human prostate cancer PC3 cells, which possess mutant p53 with a truncated COOH-terminal, and in human oropharyngeal cancer KB cells, which possess wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP897196.RAIz_Hpff7rUueE575KvsvjJ69a_NoExcQHG6ykI-xnmM130_provenance.
• NP897214.RAMF_JJCQVVvTx-Q7o-YfoDozBeZfwR-aOcrMrfxVn2o4130_assertion description "[In this study, we investigated the expression and function of p53R2 and hRRM2 after UV treatment in human prostate cancer PC3 cells, which possess mutant p53 with a truncated COOH-terminal, and in human oropharyngeal cancer KB cells, which possess wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP897214.RAMF_JJCQVVvTx-Q7o-YfoDozBeZfwR-aOcrMrfxVn2o4130_provenance.
• NP418536.RA1PED4yc_DqYiRaNmJ9J7bBIaPZ6T4rY5EpwHYWtq7vE130_assertion description "[In this study, we investigated the expression and function of p53R2 and hRRM2 after UV treatment in human prostate cancer PC3 cells, which possess mutant p53 with a truncated COOH-terminal, and in human oropharyngeal cancer KB cells, which possess wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418536.RA1PED4yc_DqYiRaNmJ9J7bBIaPZ6T4rY5EpwHYWtq7vE130_provenance.
• NP418539.RA5LWmOnM7gd2feUSIRnXC6SwMzlsFVahWOJKzuCxtXkY130_assertion description "[In this study, we investigated the expression and function of p53R2 and hRRM2 after UV treatment in human prostate cancer PC3 cells, which possess mutant p53 with a truncated COOH-terminal, and in human oropharyngeal cancer KB cells, which possess wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418539.RA5LWmOnM7gd2feUSIRnXC6SwMzlsFVahWOJKzuCxtXkY130_provenance.
• NP418542.RA9KqhZTEqz9cNN2LEuxybUsiUF-dIj-JVR3EhF7oj3MY130_assertion description "[In this study, we investigated the expression and function of p53R2 and hRRM2 after UV treatment in human prostate cancer PC3 cells, which possess mutant p53 with a truncated COOH-terminal, and in human oropharyngeal cancer KB cells, which possess wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418542.RA9KqhZTEqz9cNN2LEuxybUsiUF-dIj-JVR3EhF7oj3MY130_provenance.